2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Dennis J. Slamon, MD, PhD, discusses how his passion for medicine stemmed from a high school biology class, the struggle to develop trastuzumab as a viable drug in HER2-positive breast cancer, and the movie about his research that he didn’t want to see made.
Welcome to OncLive On Air. I'm your host today, Jason Harris. OncLive On Air is a podcast from OncLive, which provides oncology professional with the resources and information they need to provide the best patient care.
In both digital and print formats, OncLive covers every angle of oncology practice, from new technologies to treatment advances to important regulatory decisions.
In today's episode, Dennis J. Slamon, MD, PhD, discusses how his passion for medicine stemmed from a high school biology class, the struggle to develop trastuzumab (Herceptin) as a viable drug in HER2-positive breast cancer, and the movie about his research that he didn’t want to see made.